Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM) José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;

Cardiorenal unit in advanced cardiorenal disease: Clinical impact and reduction of hospital costs Eliecer Soriano Payá; Ismael Arco Adamuz; Ana María García Girón; Francisco José Bermúdez Jiménez; Elisa Berta Pereira Pérez; Laura Jordán Martínez; María Carmen Olvera-Porcel; Leticia García Mochón; Silvia López Fernández; María José Espigares Huete;